Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 09, 2024 10:43 ET | Source: Precedence Research

Ulcerative Colitis Treatment Market Size Expected to Reach USD 14.77 Bn by 2033

Ottawa, May 09, 2024 (GLOBE NEWSWIRE) -- The global ulcerative colitis treatment market size was valued at USD 10.16 billion in 2023 and is predicted to hit around USD 13.81 billion by 2032, a study...
October 24, 2023 13:00 ET | Source: DelveInsight Business Research LLP

Ulcerative Colitis Market to Grow Positively by 2032, Predicts DelveInsight | Key Companies - Arena, Pfizer, Abivax, InDex, AbbVie, Boehringer Ingelheim, Janssen Pharmaceuticals, Landos Biopharma, NImmune, Merck, Mesoblast

New York, USA, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Ulcerative Colitis Market to Grow Positively by 2032, Predicts DelveInsight | Key Companies - Arena, Pfizer, Abivax, InDex, AbbVie, Boehringer...
July 21, 2023 04:03 ET | Source: Triastek, Inc.

Triastek Reports Positive FIH Results from Study of T21, a 3D Printed Oral Treatment for Moderate to Severe Ulcerative Colitis

The study verified the ability for Triastek's 3D Microstructure for Colon Targeting (3DμS-CT) to precisely target and release medication in the colonNanjing, July 21, 2023 (GLOBE NEWSWIRE) --...
July 20, 2023 07:00 ET | Source: Triastek, Inc.

Triastek Reports Positive FIH Results from Study of T21, a 3D Printed Oral Treatment for Moderate to Severe Ulcerative Colitis

The study verified the ability for Triastek's 3D Microstructure for Colon Targeting (3DμS-CT) to precisely target and release medication in the colon Nanjing, July 20, 2023 (GLOBE NEWSWIRE) --...
March 30, 2021 20:40 ET | Source: DelveInsight Business Research LLP

A myriad of drugs are in the pipeline for Ulcerative Colitis treatment: DelveInsight

Los Angeles, USA, March 30, 2021 (GLOBE NEWSWIRE) -- A myriad of drugs are in the pipeline for Ulcerative Colitis treatment: DelveInsight The Ulcerative Colitis drug pipeline is robust with 100+...